A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...

Neoadjuvant PD-1 blockade in mismatch repair-deficient or microsatellite instability-high, locally advanced and resectable colorectal cancer: A retrospective real-world analysis. This is an ASCO ...

Landscape of MET genomic alterations in colorectal cancer (CRC). VEGF-A as a prognostic indicator in advanced gastric and colorectal cancers and correlation with immune suppression involving ...

Cancer immunotherapy drugs, which boost the immune system to fight the tumour, have revolutionised the treatment of the deficient subtype of colorectal cancer. However, these drugs only work in ...

This is a colostomy. Immunotherapy is a key treatment for either early or advanced stage colorectal cancer. Drugs called immune checkpoint inhibitors target proteins that normally prevent the ...

Colorectal cancer (CRC), which affects the colon or rectum, represents a significant public health challenge. It ranks as the ...

Cancer immunotherapy drugs, which boost the immune system to fight the tumor, have revolutionized the treatment of the deficient subtype of colorectal cancer. However, these drugs only work in ...

Researchers discovered that gut microbiota-derived hexa-acylated LPS enhances the effectiveness of anti-PD-1 cancer ...

Photoimmunotherapy is an innovative cancer treatment that combines phototherapy with immunotherapy to selectively target and ...

When a Wheaton woman’s cancer treatment was denied days before it was supposed to start, her desperate posts for help gained ...

University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65 per cent. Over 12 ...